Invest now

Bharat Parenterals share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • 1,315.60(-2.51%)
    August 17, 2026 15:50:47 PM IST
    • NSE
    • BSE
  • Vol : 11.38 K (NSE + BSE)
    Last 20 day avg : 1.49 K
Bharat Parenterals is trading -2.51% lower at Rs 1,315.60 as compared to its last closing price. Bharat Parenterals has been trading in the price range of 1,360.00 & 1,275.50. Bharat Parenterals has given 11.58% in this year & -1.86% in the last 5 days. Listed peers of Bharat Parenterals include Sun Pharmaceutical Industries (-2.20%), Divi's Laboratories (-0.06%), Torrent Pharmaceuticals (1.13%).The Mutual Fund holding in Bharat Parenterals was at -% in . The MF holding has - from the last quarter. The FII holding in Bharat Parenterals was at 0.11% in 30 Jun 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 17 Aug 2026, 11:24 PM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.62
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.45
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.07
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,275.50
Highest
1,360.00
52 week range
Lowest
880.25
Highest
1,559.90
Bharat Parenterals Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
1,882.50-2.204,51,664.1739.535.710.800.47
Divi's Laboratories
8,495.00-0.062,25,515.5678.7512.330.390.03
Torrent Pharmaceuticals
4,895.001.131,86,183.4174.4919.680.78141.16
Cipla
1,430.00-1.381,15,523.0028.653.460.881.11
Zydus Lifesciences
1,132.00-0.701,12,917.4420.804.170.0914.22
Bharat Parenterals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-05Quarterly Results & A.G.M.
2026-05-18Audited Results & Final Dividend
2026-01-30Quarterly Results
2025-11-12Quarterly Results
2025-07-28Quarterly Results & A.G.M.
About the company Bharat Parenterals
  • IndustryBiotechnology & Drugs
  • ISININE365Y01019
  • BSE Code541096
  • NSE Code
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing generic and specialty formulations. The Company offers a range of products, including antibiotics, anaesthetics, quinolones, antifungal, analgesic, antimalarial, cardiovascular system, central nervous system, gastrointestinal / alimentary system, erectile dysfunction, supplements, and steroids & hormones. The Company's subsidiaries include Innoxel Lifesciences Private Limited, Varenyam Biolifesciences Private Limited, and Varenyam Healthcare Private Limited.
  • Management Info
  • Bharatkumar DesaiManaging Director, Executive Chairman of the Board
  • Jignesh ShahChief Financial Officer
  • Sharmin SoniCompany Secretary and Compliance Officer
  • Hemang ShahExecutive Director
Bharat Parenterals Share Price FAQs

Bharat Parenterals is trading at 1315.60 as on Mon Aug 17 2026 10:20:47. This is -2.51% lower as compared to its previous closing price of 1349.45.

The market capitalization of Bharat Parenterals is 910.90 Cr as on Mon Aug 17 2026 10:20:47.

The 52 wk high for Bharat Parenterals is 1559.90 whereas the 52 wk low is 880.25

Bharat Parenterals can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 32.90
  • Dividend Yield: 0.07%
  • D/E ratio: -

Bharat Parenterals reported a net profit of - Cr in -.